Search results summary
From Health Canada
Search criteria
- Status: Select all
- AIG: 0115008001
Search results
Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
---|---|---|---|---|---|---|---|---|---|
Cancelled Post Market | 02349191 | SANIS HEALTH INC | ALPRAZOLAM | Human | Yes | Targeted (CDSA IV) | 1 | ALPRAZOLAM | 0.25 MG |
Cancelled Pre Market | 02434601 | JAMP PHARMA CORPORATION | ALPRAZOLAM | Human | Yes | Targeted (CDSA IV) | 1 | ALPRAZOLAM | 0.25 MG |
Cancelled Post Market | 02230074 | PREMPHARM INC | ALPRAZOLAM TABLETS 0.25 | Human | No | Targeted (CDSA IV) | 1 | ALPRAZOLAM | 0.25 MG |
Marketed | 00865397 | APOTEX INC | APO-ALPRAZ | Human | Yes | Targeted (CDSA IV) | 1 | ALPRAZOLAM | 0.25 MG |
Approved | 02397021 | JAMP PHARMA CORPORATION | JAMP ALPRAZOLAM | Human | Yes | Targeted (CDSA IV) | 1 | ALPRAZOLAM | 0.25 MG |
Cancelled Post Market | 02400111 | JAMP PHARMA CORPORATION | JAMP-ALPRAZOLAM | Human | Yes | Targeted (CDSA IV) | 1 | ALPRAZOLAM | 0.25 MG |
Cancelled Post Market | 02137534 | MYLAN PHARMACEUTICALS ULC | MYLAN-ALPRAZOLAM | Human | Yes | Targeted (CDSA IV) | 1 | ALPRAZOLAM | 0.25 MG |
Cancelled Post Market | 02417634 | NATCO PHARMA (CANADA) INC | NAT-ALPRAZOLAM | Human | Yes | Targeted (CDSA IV) | 1 | ALPRAZOLAM | 0.25 MG |
Cancelled Pre Market | 02346990 | TEVA CANADA LIMITED | NTP-ALPRAZOLAM | Human | Yes | Targeted (CDSA IV) | 1 | ALPRAZOLAM | 0.25 MG |
Cancelled Post Market | 01913239 | NU-PHARM INC | NU-ALPRAZ TAB 0.25MG | Human | No | Targeted (CDSA IV) | 1 | ALPRAZOLAM | .25 MG |
Marketed | 01908189 | PRO DOC LIMITEE | PRO-ALPRAZOLAM | Human | Yes | Targeted (CDSA IV) | 1 | ALPRAZOLAM | 0.25 MG |
Cancelled Post Market | 00677485 | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | RATIO-ALPRAZOLAM | Human | No | Targeted (CDSA IV) | 1 | ALPRAZOLAM | 0.25 MG |
Cancelled Post Market | 02404877 | LABORATOIRE RIVA INC. | RIVA-ALPRAZOLAM | Human | Yes | Targeted (CDSA IV) | 1 | ALPRAZOLAM | 0.25 MG |
Cancelled Pre Market | 02242107 | LABORATOIRE RIVA INC. | RIVA-ALPRAZOLAM 0.25 MG | Human | No | Targeted (CDSA IV) | 1 | ALPRAZOLAM | 0.25 MG / TAB |
Marketed | 01913484 | TEVA CANADA LIMITED | TEVA-ALPRAZOLAM | Human | Yes | Targeted (CDSA IV) | 1 | ALPRAZOLAM | 0.25 MG |
Marketed | 00548359 | BGP PHARMA ULC | XANAX | Human | Yes | Targeted (CDSA IV) | 1 | ALPRAZOLAM | 0.25 MG |
Application information
Related information
Contact us
Version 4.0.3